GLOBAL DRUG DELIVERY MARKET FORECAST 2018-2026

  • You are here:
  • Home
  • Reports
  • GLOBAL DRUG DELIVERY MARKET FORECAST 2018-2026

GLOBAL DRUG DELIVERY MARKET FORECAST 2018-2026

The global drug delivery market is anticipated to grow at a CAGR of 11.26% between 2018 and 2026. The important drivers increasing growth in the global drug delivery market is the technological advancements and the increasing use of biologic drugs. Technological advancements in the drug delivery technology are one of the key factors for the market growth.

GLOBAL DRUG DELIVERY MARKET FORECAST 2018-2026

 Global Drug Delivery Market by Route of Administration (Oral Drug Delivery, Solid Oral Drugs, Liquid Oral Drugs, Semi-solid Oral Drugs, Injectable Drug Delivery, Formulations, Topical Drug Delivery, Ocular Drug Delivery, Ocular Devices, Nasal Drug Delivery, Pulmonary Drug Delivery, Implantable Drug Delivery) by End User (Hospitals, Ambulatory Surgical Centers, Home Care Settings, Diagnostic Centers, Other End User) by Geography.

Request free sample

The global drug delivery market is anticipated to grow at a CAGR of 11.26% between 2018 and 2026. Significant factors driving the market growth include:

  • Technological advancements
  • Increasing use of biological drugs
  • Swelling demand for effective drug delivery mechanisms
  • Increase in the prevalence of chronic diseases

Drug Delivery Market

To know more about this report, request a free sample copy.

The important drivers increasing growth in the global drug delivery market is the technological advancements and the increasing use of biologic drugs. Technological advancements in the drug delivery technology are one of the key factors for the market growth. In the drug delivery industry, the introduction of new delivery platforms is expected to introduce technology that optimizes a drug’s therapeutic value in order to find a better way to get a drug into the patient’s body with a safe and in a consist way that may lead to better compliance and outcome. Biologic drugs are widely used for the treatment of diseases and conditions such as chronic diseases, ulcerative colitis, rheumatoid arthritis and other autoimmune diseases are one of the most advanced therapies.

There are different routes of administration of drugs. They are oral drug delivery injectable drug delivery, topical drug delivery, ocular drug delivery, nasal drug delivery, pulmonary drug delivery, transmucosal drug delivery and implantable drug delivery. Oral drug delivery is the most preferred medium of administration for many important drugs in various therapeutic areas. Various injectable drug delivery technologies include conventional injection devices (e.g. syringes), self-injection devices (e.g. needle-free injectors, wearable injectors) and formulations. Topical drug delivery is a localized drug delivery technology anywhere in the body through rectal, ophthalmic, vaginal and skin as topical routes. Ocular drug delivery is connected with the treatment of ophthalmic diseases. Ocular drugs are generally administered into the affected area for absorption and quick onset of action feasible. The nasal route of drug delivery can be used for both local and systemic drug delivery is majorly used to treat conditions related to the nasal cavity that includes rhinitis, congestion, sinusitis, related allergic conditions, etc. The pulmonary drug delivery system is subjected to the growth of simple, cost-effective and easy to use drug delivery devices. Implantable drug delivery is capable of reducing the frequency of patient-driven dosing and delivers the compound in a targeted manner.

Increasing drug recalls and drug failures and government regulations delaying the processes are the major factors hindering the drug delivery market. Increasing drug recalls and drug failures is expected to restrain the market growth over the forecast period. New compounds and drugs take a long time to gain approvals in the US market. Companies are facing issues related to delayed product launches due to the long and expensive approval process.

The global drug delivery market segments include routes of administration and end users.

Routes of administration are segmented into:

  • oral drug delivery
    • Solid oral drugs
    • Capsules
    • Pills
    • Powders
    • Tablets
    • Liquid oral drugs
    • Solutions
    • Syrups
    • Semi-solid oral drugs
    • Elixirs
    • Oral emulsions
    • Gels
  • Injectable drug delivery
    • Devices
    • Conventional injection devices
    • Self-injection devices
    • Other injector devices
    • Formulations
    • Conventional drug delivery injections
    • Long-acting injectable
    • Novel drug delivery formulations
  • Topical drug delivery
    • Formulations
    • Liquid topical drug delivery
    • Solid topical drug delivery
    • Semi-solid topical drug delivery
    • Devices
  • Ocular drug delivery
    • Formulations
    • Liquid formulation
    • Semi-solid formulations
    • Ocular devices
    • Drug-coated contact lenses
    • Ocular insert
  • Nasal drug delivery
    • Nasal drops
    • Nasal sprays
    • Nasal powders
    • Nasal gels
  • Pulmonary drug delivery
    • Formulations
    • Devices
    • Metered dose inhalers (MDIS)
    • Dry powder system
    • Nebulizers
  • Implantable drug delivery
    • Passive implantable drug delivery
    • Active implantable drug delivery

End users are segmented into:

  • Hospitals
  • Ambulatory surgical centers
  • Home care settings
  • Diagnostic centers
  • Other end user

This report covers the present market conditions and the growth projections of the global drug delivery market for 2018-2026 and deliberated the revenue produced through the sales of drug delivery for routes of administration and end users to calculate the market size by considering 2017 as the base year.

Geographically, the global drug delivery market has been segmented on the basis of four major regions, which include:

  • North America Drug Delivery Market : The United States & Canada
  • Asia-Pacific Drug Delivery Market : China, India, Japan, Australia, South Korea & Rest of APAC
  • Europe Drug Delivery Market: The United Kingdom, France, Germany, Spain, Italy & Rest of Europe
  • Rest of World: Latin America & Middle East and Africa

The drug delivery market in North America is expected to hold the largest share by 2026 owing to the government funding to develop novel drug delivery technologies and growing pharmaceutical industry along with the high prevalence of asthma. Moreover, technological advancements in oral drug delivery technology and high prevalence of cancer are also some other factors that are expected to boost the growth of the drug delivery technology market in North America. On the other hand, the Asia-Pacific market is anticipated to be the fastest-growing region for the drug delivery market. The Asia-pacific drug delivery technology market is expected to be on an upsurging trend owing to rising focus to boost biologic sector along with the high prevalence of cancer, rising prevalence of cardiovascular disease, growing pharmaceutical industry and technological advancements in oral drug delivery technology.

The drug delivery market is segmented based on end-users who are sub-divided into hospitals, ambulatory surgical centers, home care settings, diagnostic centers and other end-user. The substantial occurrence of diseases globally increases the need for treatment at hospitals that deploy drug delivery technology. Ambulatory surgical centers/clinics deploy drug delivery technology for administering the drugs to patients on an immediate basis or under emergency conditions. A substantial prevalence of asthma disease globally is expected to boost the adoption of inhalers at homes as a preventive medicine and thereby, drives the global drug delivery technology market growth by home care settings segment. Diagnostic centers deploy drug delivery technology to inject a special dye, referred to as a contrast medium, which is being injected into the patient’s body or given as a pill to swallow prior to the scan or imaging. Other end user segment comprises of a nursing home, birth centers, and research centers.

The major market players of the global drug delivery market are:

  • 3m Company
  • Bayer Ag
  • Antares Pharma
  • Generex Biotechnology
  • Johnson & Johnson Inc

Company Profiles covers analysis of important players.

3M Company businesses are diversified into technology, industrial, safety and graphics, healthcare, electronics and energy, and consumer. The healthcare segment serves as a market for medical clinics, hospitals, pharmaceuticals and dental. 3M is the supplier of medical tape, dressing, wound closure product, and orthopaedic casting material. Johnson & Johnson Inc provides pharmaceuticals products to treat disorders related to metabolism, cardiology, oncology, neurology, and immunology; and medical products used in diabetes care, cardiovascular, surgery and orthopaedic. Their consumer products include health and personal care products such as baby care, oral care, nutritional, skin care, etc.

Key Findings of the global drug delivery market:

  • Increasing prevalence of chronic diseases
  • Oral drug delivery market holds the largest market share in terms of the route of administration
  • Hospital segment is the biggest market in terms of end users
  • Injectable drug delivery market is anticipated to grow significantly during the forecast period
  1. RESEARCH SCOPE
    • STUDY GOALS
    • SCOPE OF THE MARKET STUDY
    • WHO WILL FIND THIS REPORT USEFUL?
    • STUDY AND FORECASTING YEARS
  2. RESEARCH METHODOLOGY
    • SOURCES OF DATA
      • SECONDARY DATA
      • PRIMARY DATA
    • TOP DOWN APPROACH
    • BOTTOM-UP APPROACH
    • DATA TRIANGULATION
  3. EXECUTIVE SUMMARY
    • KEY FINDINGS
    • KEY FINDINGS
      • INCREASING PREVALENCE OF CHRONIC DISEASES
      • ORAL DRUG DELIVERY MARKET HOLDS THE LARGEST MARKET SHARE IN TERMS OF ROUTE OF ADMINISTRATION
      • HOSPITAL SEGMENT IS THE BIGGEST MARKET IN TERMS OF END USERS
      • INJECTABLE DRUG DELIVERY MARKET IS ANTICIPATED TO GROW SIGNIFICANTLY DURING THE FORECAST PERIOD
  1. MARKET DETERMINANTS
    • MARKET DRIVERS
      • TECHNOLOGICAL ADVANCEMENTS
      • INCREASING USE OF BIOLOGICAL DRUGS
      • SWELLING DEMAND FOR EFFECTIVE DRUG DELIVERY MECHANISMS
      • CHRONIC DISEASES ARE INCREASING SIGNIFICANTLY
    • MARKET RESTRAINTS
      • INCREASING DRUG RECALLS AND DRUG FAILURES
      • GOVERNMENT REGULATIONS DELAYING THE PROCESSES
      • SIDE EFFECTS AND RISK ASSOCIATED WITH THE DRUGS
    • MARKET OPPORTUNITIES
      • RISING DEMAND FOR COST-EFFECTIVE HEALTHCARE TREATMENT
      • GROWING FOCUS TOWARDS HOME CARE AND SELF-ADMINISTRATION
    • MARKET CHALLENGES
      • PRICING PRESSURE
      • PATENTS EXPIRY
  1. MARKET SEGMENTATION
    • MARKET BY ROUTE OF ADMINISTRATION
      • ORAL DRUG DELIVERY
        • SOLID ORAL DRUGS
          • CAPSULES
          • PILLS
          • POWDERS
          • TABLETS
        • LIQUID ORAL DRUGS
          • SOLUTIONS
          • SYRUPS
        • SEMI-SOLID ORAL DRUGS
          • ELIXIRS
          • ORAL EMULSIONS
          • GELS
        • INJECTABLE DRUG DELIVERY
          • DEVICES
            • CONVENTIONAL INJECTION DEVICES
            • SELF-INJECTION DEVICES
            • OTHER INJECTOR DEVICES
          • FORMULATIONS
            • CONVENTIONAL DRUG DELIVERY INJECTIONS
            • LONG-ACTING INJECTABLE
            • NOVEL DRUG DELIVERY FORMULATIONS
          • TOPICAL DRUG DELIVERY
            • FORMULATIONS
              • LIQUID TOPICAL DRUG DELIVERY
              • SEMI-SOLID TOPICAL DRUG DELIVERY
              • SOLID TOPICAL DRUG DELIVERY
            • DEVICES
          • OCULAR DRUG DELIVERY
            • FORMULATIONS
              • LIQUID FORMULATION
              • SEMI-SOLID FORMULATIONS
            • OCULAR DEVICES
              • DRUG-COATED CONTACT LENSES
              • OCULAR INSERT
            • NASAL DRUG DELIVERY
              • NASAL DROPS
              • NASAL SPRAYS
              • NASAL POWDERS
              • NASAL GELS
            • PULMONARY DRUG DELIVERY
              • FORMULATIONS
              • DEVICES
                • METERED DOSE INHALERS (MDIS)
                • DRY POWDER SYSTEM
                • NEBULIZERS
              • IMPLANTABLE DRUG DELIVERY
                • ACTIVE IMPLANTABLE DRUG DELIVERY
                • PASSIVE IMPLANTABLE DRUG DELIVERY
              • MARKET BY END USER 2018-2026
                • HOSPITALS
                • AMBULATORY SURGICAL CENTERS
                • HOME CARE SETTINGS
                • DIAGNOSTIC CENTERS
                • OTHER END USER
  1. KEY ANALYTICAL
    • PORTER’S 5 FORCES MODEL
      • THREAT OF NEW ENTRANTS
      • THREAT OF SUBSTITUTE PRODUCTS
      • BARGAINING POWER OF BUYER
      • BARGAINING POWER OF SUPPLIER
      • INTENSITY OF COMPETITIVE RIVALRY
    • MARKET ETYMOLOGY
    • ESTIMATION ANALYSIS
      • DEVELOPING PHARMACEUTICAL INDUSTRY
      • INCREASING HEALTHCARE EXPENDITURE
      • DRUGS IN PIPELINE
    • STRATEGIC ANALYSIS
    • KEY BUYING CRITERIA
    • REGULATORY FRAMEWORK
  2. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • THE UNITED STATES
      • CANADA
    • EUROPE
      • THE UNITED KINGDOM
      • FRANCE
      • GERMANY
      • SPAIN
      • ITALY
      • REST OF EUROPE
    • ASIA PACIFIC
      • CHINA
      • INDIA
      • JAPAN
      • AUSTRALIA
      • SOUTH KOREA
      • REST OF APAC
    • REST OF WORLD
      • LATIN AMERICA
      • MIDDLE EAST AND AFRICA
  1. COMPANY PROFILES
    • COMPETITIVE LANDSCAPE
      • MARKET SHARE ANALYSIS
    • 3M COMPANY
      • COMPANY OVERVIEW
      • PRODUCT PORTFOLIO
      • SCOT ANALYSIS
      • STRATEGIC INITIATIVES
    • ALKERMES PLC
      • COMPANY OVERVIEW
      • PRODUCT PORTFOLIO
      • SCOT ANALYSIS
      • STRATEGIC INITIATIVE
    • ANTARES PHARMA
      • COMPANY OVERVIEW
      • PRODUCT PORTFOLIO
      • STRATEGIC INITIATIVES
    • BAYER AG
      • COMPANY OVERVIEW
      • PRODUCT PORTFOLIO
      • SCOT ANALYSIS
      • STRATEGIC INITIATIVE
    • BECTON, DICKINSON & COMPANY (BD)
      • COMPANY OVERVIEW
      • PRODUCT PORTFOLIO
      • SCOT ANALYSIS
      • STRATEGIC INITIATIVES
    • HOFFMANN-LA ROCHE LTD
      • COMPANY OVERVIEW
      • PRODUCT PORTFOLIO
      • SCOT ANALYSIS
      • STRATEGIC INITIATIVES
    • GENEREX BIOTECHNOLOGY
      • COMPANY OVERVIEW
      • PRODUCTS PORTFOLIO
      • SCOT ANALYSIS
    • GLAXOSMITHKLINE
      • COMPANY OVERVIEW
      • PRODUCT PORTFOLIO
      • SCOT ANALYSIS
      • STRATEGIC INITIATIVES
    • JOHNSON & JOHNSON INC.
      • COMPANY OVERVIEW
      • PRODUCT PORTFOLIO
      • SCOT ANALYSIS
      • STRATEGIC INITIATIVES
    • NOVARTIS
      • COMPANY OVERVIEW
      • PRODUCT PORTFOLIO
      • SCOT ANALYSIS
      • STRATEGIC INITIATIVES
    • PSIVIDA CORPORATION (EYEPOINT PHARMACEUTICALS, INC.)
      • COMPANY OVERVIEW
      • PRODUCTS PORTFOLIO
      • SCOT ANALYSIS
      • STRATEGIC INITIATIVES
    • VECTURA GROUP PLC (UK)
      • COMPANY OVERVIEW
      • PRODUCTS PORTFOLIO
      • SCOT ANALYSIS
      • STRATEGIC INITIATIVES

LIST OF TABLES

TABLE  1      GLOBAL DRUG DELIVERY MARKET BY GEOGRAPHY 2018-2026 ($ BILLION)

TABLE  2      COMPANIES INVESTING IN BIOPHARMACEUTICALS

TABLE  3      GLOBAL DRUG DELIVERY MARKET BY ROUTE OF ADMINISTRATION 2018-2026

TABLE  4      GLOBAL DRUG DELIVERY MARKET IN ORAL DRUG DELIVERY BY GEOGRAPHY 2018-2026

TABLE  5      GLOBAL DRUG DELIVERY MARKET IN ORAL DRUG DELIVERY BY TYPES 2018-2026

TABLE  6      GLOBAL ORAL DRUG DELIVERY MARKET IN SOLID ORAL DRUGS BY TYPES 2018-2026

TABLE  7      GLOBAL ORAL DRUG DELIVERY MARKET IN LIQUID ORAL DRUGS BY TYPES 2018-2026

TABLE  8      GLOBAL ORAL DRUG DELIVERY MARKET IN SEMI-SOLID ORAL DRUGS BY TYPES 2018-2026

TABLE  9      GLOBAL DRUG DELIVERY MARKET IN INJECTABLE DRUG DELIVERY BY GEOGRAPHY 2018-2026

TABLE  10    GLOBAL DRUG DELIVERY MARKET IN INJECTABLE DRUG DELIVERY BY TYPES 2018-2026

TABLE  11    GLOBAL INJECTABLE DRUG DELIVERY MARKET IN DEVICES 2018-2026

TABLE  12    GLOBAL DEVICES MARKET IN CONVENTIONAL INJECTION DEVICES BY MATERIAL 2018-2026

TABLE  13    GLOBAL DEVICES MARKET IN CONVENTIONAL INJECTION DEVICES BY PRODUCT 2018-2026

TABLE  14    GLOBAL DEVICES MARKET IN CONVENTIONAL INJECTION DEVICES BY USABILITY 2018-2026

TABLE  15    GLOBAL DEVICES MARKET IN SELF-INJECTION DEVICES BY TYPES 2018-2026

TABLE  16    GLOBAL INJECTABLE DRUG DELIVERY MARKET IN FORMULATIONS BY TYPES 2018-2026

TABLE  17    GLOBAL DRUG DELIVERY MARKET IN TOPICAL DRUG DELIVERY BY GEOGRAPHY 2018-2026

TABLE  18    GLOBAL DRUG DELIVERY MARKET IN TOPICAL DRUG DELIVERY BY TYPES 2018-2026

TABLE  19    GLOBAL TOPICAL DRUG DELIVERY MARKET IN FORMULATIONS BY TYPES 2018-2026

TABLE  20    GLOBAL FORMULATIONS MARKET IN LIQUID TOPICAL DRUG DELIVERY BY TYPES 2018-2026

TABLE  21    GLOBAL FORMULATIONS MARKET IN SEMI-SOLID TOPICAL DRUG DELIVERY BY TYPES 2018-2026

TABLE  22    GLOBAL FORMULATIONS MARKET IN SOLID TOPICAL DRUG DELIVERY BY TYPES 2018-2026

TABLE  23    GLOBAL TOPICAL DRUG DELIVERY MARKET IN DEVICES BY TYPES 2018-2026

TABLE  24    GLOBAL DRUG DELIVERY MARKET IN OCULAR DRUG DELIVERY BY GEOGRAPHY 2018-2026

TABLE  25    GLOBAL DRUG DELIVERY MARKET IN OCULAR DRUG DELIVERY BY TYPES 2018-2026

TABLE  26    GLOBAL OCULAR DRUG DELIVERY MARKET IN FORMULATIONS BY TYPES 2018-2026

TABLE  27    GLOBAL FORMULATIONS MARKET IN LIQUID FORMULATION BY TYPES 2018-2026

TABLE  28    GLOBAL FORMULATION MARKET IN SEMI-SOLID FORMULATIONS BY TYPE 2018-2026

TABLE  29    GLOBAL OCULAR DRUG DELIVERY MARKET IN OCULAR DEVICES BY TYPES 2018-2026

TABLE  30    GLOBAL DRUG DELIVERY MARKET IN NASAL BY GEOGRAPHY 2018-2026

TABLE  31    GLOBAL DRUG DELIVERY MARKET IN NASAL BY TYPES 2018-2026

TABLE  32    GLOBAL DRUG DELIVERY MARKET IN PULMONARY BY GEOGRAPHY 2018-2026

TABLE  33    GLOBAL DRUG DELIVERY MARKET IN PULMONARY BY TYPES 2018-2026

TABLE  34    GLOBAL PULMONARY MARKET IN DEVICES BY TYPES 2018-2026

TABLE  35    GLOBAL DEVICES MARKET IN NEBULIZERS BY TYPES 2018-2026

TABLE  36    GLOBAL DRUG DELIVERY MARKET IN IMPLANTABLE DRUG DELIVERY BY GEOGRAPHY 2018-2026

TABLE  37    GLOBAL DRUG DELIVERY MARKET IN IMPLANTABLE DRUG DELIVERY BY TYPES 2018-2026

TABLE  38    GLOBAL DRUG DELIVERY MARKET BY END USER 2018-2026

TABLE  39    GLOBAL DRUG DELIVERY MARKET IN HOSPITALS BY GEOGRAPHY 2018-2026

TABLE  40    GLOBAL DRUG DELIVERY MARKET IN AMBULATORY SURGICAL CENTERS BY GEOGRAPHY 2018-2026

TABLE  41    GLOBAL DRUG DELIVERY MARKET IN HOME CARE SETTINGS BY GEOGRAPHY 2018-2026

TABLE  42    GLOBAL DRUG DELIVERY MARKET IN DIAGNOSTIC CENTERS BY GEOGRAPHY 2018-2026

TABLE  43    GLOBAL DRUG DELIVERY MARKET IN OTHER END USER BY GEOGRAPHY 2018-2026

TABLE  44    PIPELINE DRUGS (2017)

TABLE  45    GLOBAL DRUG DELIVERY MARKET BY GEOGRAPHY 2018-2026

TABLE  46    NORTH AMERICA DRUG DELIVERY MARKET 2018-2026

TABLE  47    THE UNITED STATES DRUG DELIVERY MARKET BY ROUTE OF ADMINISTRATION 2018-2026

TABLE  48    CANADA DRUG DELIVERY MARKET BY ROUTE OF ADMINISTRATION 2018-2026

TABLE  49    EUROPE DRUG DELIVERY MARKET 2018-2026

TABLE  50    THE UNITED KINGDOM DRUG DELIVERY MARKET BY ROUTE OF ADMINISTRATION 2018-2026

TABLE  51    FRANCE DRUG DELIVERY MARKET BY ROUTE OF ADMINISTRATION 2018-2026

TABLE  52    GERMANY DRUG DELIVERY MARKET BY ROUTE OF ADMINISTRATION 2018-2026

TABLE  53    SPAIN DRUG DELIVERY MARKET BY ROUTE OF ADMINISTRATION 2018-2026

TABLE  54    ASIA PACIFIC DRUG DELIVERY MARKET 2018-2026

TABLE  55    CHINA DRUG DELIVERY MARKET BY ROUTE OF ADMINISTRATION 2018-2026

TABLE  56    INDIA DRUG DELIVERY MARKET BY ROUTE OF ADMINISTRATION 2018-2026

TABLE  57    JAPAN DRUG DELIVERY MARKET BY ROUTE OF ADMINISTRATION 2018-2026

TABLE  58    AUSTRALIA DRUG DELIVERY MARKET BY ROUTE OF ADMINISTRATION 2018-2026

TABLE  59    REST OF WORLD DRUG DELIVERY MARKET 2018-2026

TABLE  60    LATIN AMERICA DRUG DELIVERY MARKET BY ROUTE OF ADMINISTRATION 2018-2026

TABLE  61    MIDDLE EAST AND AFRICA DRUG DELIVERY MARKET BY ROUTE OF ADMINISTRATION 2018-2026

LIST OF FIGURES

FIGURE  1    GLOBAL DRUG DELIVERY MARKET BY GEOGRAPHY 2018-2026 ($ BILLION)

FIGURE  2    GLOBAL DRUG DELIVERY MARKET IN ORAL DRUG DELIVERY 2018-2026

FIGURE  3    GLOBAL SOLID ORAL DRUGS MARKET IN CAPSULES 2018-2026

FIGURE  4    GLOBAL SOLID ORAL DRUGS MARKET IN PILLS 2018-2026

FIGURE  5    GLOBAL SOLID ORAL DRUGS MARKET IN POWDERS 2018-2026

FIGURE  6    GLOBAL SOLID ORAL DRUGS MARKET IN TABLETS 2018-2026

FIGURE  7    GLOBAL LIQUID ORAL DRUGS MARKET IN SOLUTIONS 2018-2026

FIGURE  8    GLOBAL LIQUID ORAL DRUGS MARKET IN SYRUPS 2018-2026

FIGURE  9    GLOBAL SEMI-SOLID ORAL DRUGS MARKET IN ELIXIRS 2018-2026

FIGURE  10  GLOBAL SEMI-SOLID ORAL DRUGS MARKET IN ORAL EMULSIONS  2018-2026

FIGURE  11  GLOBAL SEMI-SOLID ORAL DRUGS MARKET IN GELS 2018-2026

FIGURE  12  GLOBAL DRUG DELIVERY MARKET IN INJECTABLE DRUG DELIVERY 2018-2026

FIGURE  13  GLOBAL CONVENTIONAL INJECTION DEVICES  IN GLASS 2018-2026

FIGURE  14  GLOBAL CONVENTIONAL INJECTION DEVICES  IN PLASTIC 2018-2026

FIGURE  15  GLOBAL CONVENTIONAL INJECTION DEVICES  IN FILLABLE SYRINGES 2018-2026

FIGURE  16  GLOBAL CONVENTIONAL INJECTION DEVICES  IN PREFILLED SYRINGES 2018-2026

FIGURE  17  GLOBAL CONVENTIONAL INJECTION DEVICES  IN REUSABLE SYRINGES 2018-2026

FIGURE  18  GLOBAL CONVENTIONAL INJECTION DEVICES  IN DISPOSABLE SYRINGES 2018-2026

FIGURE  19  GLOBAL SELF-INJECTION DEVICES MARKET IN AUTO-INJECTOR  2018-2026

FIGURE  20  GLOBAL SELF-INJECTION DEVICES MARKET IN NEEDLE-FREE INJECTORS 2018-2026

FIGURE  21  GLOBAL SELF-INJECTION DEVICES MARKET IN PEN INJECTORS 2018-2026

FIGURE  22  GLOBAL SELF-INJECTION DEVICES MARKET IN WEARABLE INJECTORS 2018-2026

FIGURE  23  GLOBAL DEVICES MARKET IN OTHER INJECTOR DEVICES 2018-2026

FIGURE  24  GLOBAL FORMULATIONS MARKET IN CONVENTIONAL DRUG DELIVERY INJECTIONS  2018-2026

FIGURE  25  GLOBAL FORMULATIONS MARKET IN LONG ACTING INJECTABLE 2018-2026

FIGURE  26  GLOBAL FORMULATIONS MARKET IN NOVEL DRUG DELIVERY FORMULATIONS 2018-2026

FIGURE  27  GLOBAL LIQUID TOPICAL DRUG DELIVERY MARKET IN SOLUTIONS 2018-2026

FIGURE  28  GLOBAL LIQUID TOPICAL DRUG DELIVERY MARKET IN SUSPENSIONS 2018-2026

FIGURE  29  GLOBAL SEMI-SOLID TOPICAL DRUG DELIVERY MARKET IN CREAMS 2018-2026

FIGURE  30  GLOBAL SEMI-SOLID TOPICAL DRUG DELIVERY MARKET IN GELS 2018-2026

FIGURE  31  GLOBAL SEMI-SOLID TOPICAL DRUG DELIVERY MARKET IN OINTMENTS 2018-2026

FIGURE  32  GLOBAL SEMI-SOLID TOPICAL DRUG DELIVERY MARKET IN PASTES 2018-2026

FIGURE  33  GLOBAL SEMI-SOLID TOPICAL DRUG DELIVERY MARKET IN LOTIONS 2018-2026

FIGURE  34  GLOBAL SOLID TOPICAL DRUG DELIVERY MARKET IN SUPPOSITORIES 2018-2026

FIGURE  35  GLOBAL SOLID TOPICAL DRUG DELIVERY MARKET IN POWDERS 2018-2026

FIGURE  36  GLOBAL DEVICES MARKET IN TRANSDERMAL PATCHES 2018-2026

FIGURE  37  GLOBAL DEVICES MARKET IN TRANSDERMAL GELS 2018-2026

FIGURE  38  GLOBAL LIQUID FORMULATION MARKET IN EYE DROPS 2018-2026

FIGURE  39  GLOBAL LIQUID FORMULATION MARKET IN LIQUID SPRAYS 2018-2026

FIGURE  40  GLOBAL SEMI-SOLID FORMULATIONS MARKET IN EYE OINTMENTS  2018-2026

FIGURE  41  GLOBAL SEMI-SOLID FORMULATIONS MARKET IN GELS 2018-2026

FIGURE  42  GLOBAL OCULAR DEVICES MARKET IN DRUG-COATED CONTACT LENSES 2018-2026

FIGURE  43  GLOBAL OCULAR DEVICES MARKET IN OCULAR INSERT 2018-2026

FIGURE  44  GLOBAL NASAL MARKET IN NASAL DROPS 2018-2026

FIGURE  45  GLOBAL NASAL MARKET IN NASAL SPRAYS 2018-2026

FIGURE  46  GLOBAL NASAL MARKET IN NASAL POWDERS 2018-2026

FIGURE  47  GLOBAL NASAL MARKET IN NASAL GELS 2018-2026

FIGURE  48  GLOBAL PULMONARY MARKET IN FORMULATIONS 2018-2026

FIGURE  49  GLOBAL DEVICES MARKET IN METERED DOSE INHALERS (MDIS) 2018-2026

FIGURE  50  GLOBAL DEVICES MARKET IN DRY POWDER SYSTEM 2018-2026

FIGURE  51  GLOBAL DEVICES MARKET IN NEBULIZERS 2018-2026

FIGURE  52  GLOBAL NEBULIZERS MARKET IN JET NEBULIZERS 2018-2026

FIGURE  53  GLOBAL NEBULIZERS MARKET IN SOFT MIST NEBULIZERS 2018-2026

FIGURE  54  GLOBAL NEBULIZERS MARKET IN ULTRASONIC NEBULIZERS DELIVER 2018-2026

FIGURE  55  GLOBAL IMPLANTABLE DRUG DELIVERY MARKET IN 2018-2026

FIGURE  56  GLOBAL IMPLANTABLE DRUG DELIVERY MARKET IN 2018-2026

FIGURE  57  GLOBAL EXPENDITURE IN THE R & D OF BIOPHARMA COMPANIES ($ BILLION)

FIGURE  58  HEALTHCARE EXPENDITURE IN THE UNITED STATES  2015-2025 (% OF GDP)

FIGURE  59  DIFFERENT INSTITUTIONS  EXPENDITURE ON HEALTHCARE SPENDING 2015-2040 ($ TRILLION)

FIGURE  60  THE UNITED STATES DRUG DELIVERY MARKET 2018-2026

FIGURE  61  CANADA DRUG DELIVERY MARKET 2018-2026

FIGURE  62  THE UNITED KINGDOM DRUG DELIVERY MARKET 2018-2026

FIGURE  63  FRANCE DRUG DELIVERY MARKET 2018-2026

FIGURE  64  GERMANY DRUG DELIVERY MARKET 2018-2026

FIGURE  65  SPAIN DRUG DELIVERY MARKET 2018-2026

FIGURE  66  ITALY DRUG DELIVERY MARKET 2018-2026

FIGURE  67  REST OF EUROPE DRUG DELIVERY MARKET 2018-2026

FIGURE  68  CHINA DRUG DELIVERY MARKET 2018-2026

FIGURE  69  INDIA DRUG DELIVERY MARKET 2018-2026

FIGURE  70  JAPAN DRUG DELIVERY MARKET 2018-2026

FIGURE  71  AUSTRALIA DRUG DELIVERY MARKET 2018-2026

FIGURE  72  SOUTH KOREA DRUG DELIVERY MARKET 2018-2026

FIGURE  73  REST OF APAC DRUG DELIVERY MARKET 2018-2026

FIGURE  74  LATIN AMERICA DRUG DELIVERY MARKET 2018-2026

FIGURE  75  MIDDLE EAST AND AFRICA DRUG DELIVERY MARKET 2018-2026

FIGURE  76  MARKET SHARE ANALYSIS OF DRUG DELIVERY TECHNOLOGY MARKET 2017 (% )

  1. MARKET SEGMENTATION
    • MARKET BY ROUTE OF ADMINISTRATION
      • ORAL DRUG DELIVERY
        • SOLID ORAL DRUGS
          • CAPSULES
          • PILLS
          • POWDERS
          • TABLETS
        • LIQUID ORAL DRUGS
          • SOLUTIONS
          • SYRUPS
        • SEMI-SOLID ORAL DRUGS
          • ELIXIRS
          • ORAL EMULSIONS
          • GELS
        • INJECTABLE DRUG DELIVERY
          • DEVICES
            • CONVENTIONAL INJECTION DEVICES
            • SELF-INJECTION DEVICES
            • OTHER INJECTOR DEVICES
          • FORMULATIONS
            • CONVENTIONAL DRUG DELIVERY INJECTIONS
            • LONG-ACTING INJECTABLE
            • NOVEL DRUG DELIVERY FORMULATIONS
          • TOPICAL DRUG DELIVERY
            • FORMULATIONS
              • LIQUID TOPICAL DRUG DELIVERY
              • SEMI-SOLID TOPICAL DRUG DELIVERY
              • SOLID TOPICAL DRUG DELIVERY
            • DEVICES
          • OCULAR DRUG DELIVERY
            • FORMULATIONS
              • LIQUID FORMULATION
              • SEMI-SOLID FORMULATIONS
            • OCULAR DEVICES
              • DRUG-COATED CONTACT LENSES
              • OCULAR INSERT
            • NASAL DRUG DELIVERY
              • NASAL DROPS
              • NASAL SPRAYS
              • NASAL POWDERS
              • NASAL GELS
            • PULMONARY DRUG DELIVERY
              • FORMULATIONS
              • DEVICES
                • METERED DOSE INHALERS (MDIS)
                • DRY POWDER SYSTEM
                • NEBULIZERS
              • IMPLANTABLE DRUG DELIVERY
                • ACTIVE IMPLANTABLE DRUG DELIVERY
                • PASSIVE IMPLANTABLE DRUG DELIVERY
              • MARKET BY END USER 2018-2026
                • HOSPITALS
                • AMBULATORY SURGICAL CENTERS
                • HOME CARE SETTINGS
                • DIAGNOSTIC CENTERS
                • OTHER END USER
  1. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • THE UNITED STATES
      • CANADA
    • EUROPE
      • THE UNITED KINGDOM
      • FRANCE
      • GERMANY
      • SPAIN
      • ITALY
      • REST OF EUROPE
    • ASIA PACIFIC
      • CHINA
      • INDIA
      • JAPAN
      • AUSTRALIA
      • SOUTH KOREA
      • REST OF APAC
    • REST OF WORLD
      • LATIN AMERICA
      • MIDDLE EAST AND AFRICA

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

Choose License Type

Buy Now